双氢青蒿酸
|
D418537-250mg
|
≥98% |
85031-59-0 |
250mg
|
¥ 369.9
|
现货 |
阿拉丁 |
双氢青蒿酸
|
D418537-1g
|
≥98% |
85031-59-0 |
1g
|
¥ 1029.9
|
现货 |
阿拉丁 |
双氢青蒿酸
|
D418537-100mg
|
≥98% |
85031-59-0 |
100mg
|
¥ 278.9
|
现货 |
阿拉丁 |
双马来酸盐阿法替尼
|
A288214-5g
|
≥98% |
850140-73-7 |
5g
|
¥ 1122.9
|
现货 |
阿拉丁 |
双马来酸盐阿法替尼
|
A288214-250mg
|
≥98% |
850140-73-7 |
250mg
|
¥ 142.9
|
现货 |
阿拉丁 |
双马来酸盐阿法替尼
|
A288214-1g
|
≥98% |
850140-73-7 |
1g
|
¥ 342.9
|
现货 |
阿拉丁 |
2-氨基-4-氯吡咯并[2,3-D]嘧啶
|
B301415-5g
|
≥95% |
84955-31-7 |
5g
|
¥ 160.9
|
现货 |
阿拉丁 |
2-氨基-4-氯吡咯并[2,3-D]嘧啶
|
B301415-25g
|
≥95% |
84955-31-7 |
25g
|
¥ 1111.9
|
现货 |
阿拉丁 |
2-氨基-4-氯吡咯并[2,3-D]嘧啶
|
B301415-1g
|
≥95% |
84955-31-7 |
1g
|
¥ 32.9
|
现货 |
阿拉丁 |
2-氨基-4-氯吡咯并[2,3-D]嘧啶
|
B301415-100g
|
≥95% |
84955-31-7 |
100g
|
¥ 4428.9
|
现货 |
阿拉丁 |
4'-n-丙氧基联苯-4-硼酸(含不同量的酸酐)
|
P186931-250mg
|
≥97% |
849062-20-0 |
250mg
|
¥ 281.9
|
现货 |
阿拉丁 |
4'-n-丙氧基联苯-4-硼酸(含不同量的酸酐)
|
P186931-1g
|
≥97% |
849062-20-0 |
1g
|
¥ 678.9
|
现货 |
阿拉丁 |
WAY-655953
|
W417872-5mg
|
≥98% |
848249-35-4 |
5mg
|
¥ 1924.9
|
现货 |
阿拉丁 |
WAY-655953
|
W417872-50mg
|
≥98% |
848249-35-4 |
50mg
|
¥ 6464.9
|
现货 |
阿拉丁 |
WAY-655953
|
W417872-25mg
|
≥98% |
848249-35-4 |
25mg
|
¥ 3422.9
|
现货 |
阿拉丁 |
WAY-655953
|
W417872-10mg
|
≥98% |
848249-35-4 |
10mg
|
¥ 2566.9
|
现货 |
阿拉丁 |
WAY-655953
|
W417872-100mg
|
≥98% |
848249-35-4 |
100mg
|
¥ 9889.9
|
现货 |
阿拉丁 |
HKI 357,ErbB2和EGFR的双重不可逆抑制剂
|
H286774-5mg
|
≥98%(HPLC) |
848133-17-5 |
5mg
|
¥ 1278.9
|
现货 |
阿拉丁 |
HKI 357,ErbB2和EGFR的双重不可逆抑制剂
|
H286774-25mg
|
≥98%(HPLC) |
848133-17-5 |
25mg
|
¥ 4156.9
|
现货 |
阿拉丁 |
HKI 357,ErbB2和EGFR的双重不可逆抑制剂
|
H286774-100mg
|
≥98%(HPLC) |
848133-17-5 |
100mg
|
¥ 10780.9
|
现货 |
阿拉丁 |
4-硝基吲哚啉
|
N195276-5g
|
≥97% |
84807-26-1 |
5g
|
¥ 5436.9
|
期货,请咨询 |
阿拉丁 |
4-硝基吲哚啉
|
N195276-500mg
|
≥97% |
84807-26-1 |
500mg
|
¥ 1750.9
|
期货,请咨询 |
阿拉丁 |
4-硝基吲哚啉
|
N195276-1g
|
≥97% |
84807-26-1 |
1g
|
¥ 3089.9
|
期货,请咨询 |
阿拉丁 |
WAY-652848
|
W418264-5mg
|
≥98% |
848057-98-7 |
5mg
|
¥ 142.9
|
现货 |
阿拉丁 |